Marquice Agu

Collaborated on IP monetization and biotech scale-up case studies, advising on go-to-market strategy, pricing, and regulatory pathway alignment for startup ventures.

Built DCF and comparable-company models and analyzed regulatory and IP timelines to support valuation and go/no-go investment decisions for healthcare and biotech opportunities.

Drafted motions, pleadings, and appellate briefs in family law matters and led client intake and mediation preparation, contributing to successful settlement negotiations and clarified case strategies.

Designed and delivered patent exclusivity workshops (BPCIA/Hatch-Waxman) for STEM law students and authored a faculty-reviewed white paper analyzing biosimilar litigation trends with strategic recommendations.

Conducted DNA methylation analyses using PCR and ChIP in an epigenetics lab, contributing data to projects on cloning and genetic stability.

Activities and societies: Developed NPV models, led go-to-market strategy projects for CRISPR therapies, modeled health economics, and delivered lifecycle exclusivity analyses.

MSc in Biotechnology and Pharmaceutical Management with coursework and projects on NPV modeling, regulatory pathways (FDA/NICE), and IP/market strategy for biotech innovations.

Activities and societies: Frances Ryan Scholarship recipient; Outstanding Oralist (2x); Moot Court Board VP; VP of IP Law Society; CALI Award for Excellence.

Juris Doctor with emphasis on intellectual property and patent law; involved in moot court and awarded for oral advocacy and academic excellence.

Grade: cum laude

Activities and societies: Research assistant in epigenetics lab; AmeriCorps member; NAACP Scholarship recipient.

Bachelor of Science in Biology with a minor in Chemistry, graduated cum laude and conducted epigenetics research using PCR, qPCR, and ChIP techniques.